Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Activity Sensors to Evaluate the Effect of Sacubitril/Valsartan on Quality-of-Life in Heart Failure: rational and design of the AWAKE-HF study.

Khandwalla RM, Birkeland K, Heywood JT, Steinhubl S, McCague K, Fombu E, Grant D, Riebman JB, Owens RL.

ESC Heart Fail. 2019 Dec;6(6):1313-1321. doi: 10.1002/ehf2.12514. Epub 2019 Oct 22.

2.

Intracellular cytarabine triphosphate in circulating blasts post-treatment predicts remission status in patients with acute myeloid leukemia.

Anderson E, Rees B, Hull J, Heywood J, Preston A, Protheroe R, Foulstone E, Greenwood R, Salisbury V, Mehta P.

Exp Hematol. 2019 Jun;74:13-18.e3. doi: 10.1016/j.exphem.2019.04.005. Epub 2019 May 2.

PMID:
31054867
3.

A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.

Wicks P, McCaffrey S, Goodwin K, Black R, Hoole M, Heywood J.

J Med Internet Res. 2019 Jan 25;21(1):e12075. doi: 10.2196/12075.

4.

A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGFβ Early Response Gene that Mediates Fibroblast to Myofibroblast Transition.

Watanabe T, Baker Frost DA, Mlakar L, Heywood J, da Silveira WA, Hardiman G, Feghali-Bostwick C.

Genes (Basel). 2019 Jan 22;10(2). pii: E75. doi: 10.3390/genes10020075.

5.

Segmenting accelerometer data from daily life with unsupervised machine learning.

van Kuppevelt D, Heywood J, Hamer M, Sabia S, Fitzsimons E, van Hees V.

PLoS One. 2019 Jan 9;14(1):e0208692. doi: 10.1371/journal.pone.0208692. eCollection 2019.

6.

The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes.

Seelig E, Howlett J, Porter L, Truman L, Heywood J, Kennet J, Arbon EL, Anselmiova K, Walker NM, Atkar R, Pekalski ML, Rytina E, Evans M, Wicker LS, Todd JA, Mander AP, Bond S, Waldron-Lynch F.

JCI Insight. 2018 Oct 4;3(19). pii: 99306. doi: 10.1172/jci.insight.99306.

7.

Stiff Left Atrial Syndrome; Prospects and Possibilities. Retrospective Analysis and Review of the Literature.

Chaudhry MA, Johnson A, Heywood JT.

Curr Hypertens Rev. 2019;15(1):17-21. doi: 10.2174/1573402114666180917095654. Review.

PMID:
30221604
8.

CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML.

Anderson E, Mehta P, Heywood J, Rees B, Bone H, Robinson G, Reynolds D, Salisbury V, Mayer L.

Leuk Res. 2018 Nov;74:121-129. doi: 10.1016/j.leukres.2018.08.007. Epub 2018 Aug 11.

PMID:
30119908
9.

PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCES.

Marsh K, Caro JJ, Zaiser E, Heywood J, Hamed A.

Int J Technol Assess Health Care. 2018 Jan;34(1):105-110. doi: 10.1017/S0266462317001118. Epub 2017 Dec 26.

PMID:
29277175
10.

Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis.

Watanabe T, Nishimoto T, Mlakar L, Heywood J, Malaab M, Hoffman S, Feghali-Bostwick C.

PLoS One. 2017 Jun 26;12(6):e0179917. doi: 10.1371/journal.pone.0179917. eCollection 2017.

11.

Genetic and environmental integration of the hawkmoth pollination syndrome in Ruellia humilis (Acanthaceae).

Heywood JS, Michalski JS, McCann BK, Russo AD, Andres KJ, Hall AR, Middleton TC.

Ann Bot. 2017 May 1;119(7):1143-1155. doi: 10.1093/aob/mcx003.

12.

Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice.

Desai AS, Bhimaraj A, Bharmi R, Jermyn R, Bhatt K, Shavelle D, Redfield MM, Hull R, Pelzel J, Davis K, Dalal N, Adamson PB, Heywood JT.

J Am Coll Cardiol. 2017 May 16;69(19):2357-2365. doi: 10.1016/j.jacc.2017.03.009. Epub 2017 Mar 19.

13.

Remote Monitoring in Heart Failure: the Current State.

Mohan RC, Heywood JT, Small RS.

Curr Treat Options Cardiovasc Med. 2017 Mar;19(3):22. doi: 10.1007/s11936-017-0519-5. Review.

PMID:
28299615
14.

Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor.

Heywood JT, Jermyn R, Shavelle D, Abraham WT, Bhimaraj A, Bhatt K, Sheikh F, Eichorn E, Lamba S, Bharmi R, Agarwal R, Kumar C, Stevenson LW.

Circulation. 2017 Apr 18;135(16):1509-1517. doi: 10.1161/CIRCULATIONAHA.116.026184. Epub 2017 Feb 20.

PMID:
28219895
15.

Getting stem cell patients 'on the grid'.

Wicks P, Heywood J.

Nat Biotechnol. 2016 Dec 7;34(12):1228-1230. doi: 10.1038/nbt.3740. No abstract available.

PMID:
27926718
16.

Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial.

Todd JA, Evangelou M, Cutler AJ, Pekalski ML, Walker NM, Stevens HE, Porter L, Smyth DJ, Rainbow DB, Ferreira RC, Esposito L, Hunter KM, Loudon K, Irons K, Yang JH, Bell CJ, Schuilenburg H, Heywood J, Challis B, Neupane S, Clarke P, Coleman G, Dawson S, Goymer D, Anselmiova K, Kennet J, Brown J, Caddy SL, Lu J, Greatorex J, Goodfellow I, Wallace C, Tree TI, Evans M, Mander AP, Bond S, Wicker LS, Waldron-Lynch F.

PLoS Med. 2016 Oct 11;13(10):e1002139. doi: 10.1371/journal.pmed.1002139. eCollection 2016 Oct.

17.

Erratum: Community crystal gazing.

Acharya A, Bingham K, Bradner J, Burke W, Charo RA, Cherry J, Choulika A, Coles T, Cook-Deegan R, Crook ST, Díaz E, Erickson B, Giddings LV, Giwa SE, Greenwood JC, Gulati V, Hall S, Harris J, Heywood J, Hill C, Levin J, Mangubat A, Maraganore J, Mariggi G, Mazur BJ, McGuire AL, Moll N, Moreno J, Naughton G, Nelsen L, Osbourn J, Perez D, Reed J, Schmidt E, Seyfert-Margolis V, Stoffels P, Thorball J, O'Toole T, Vainu I, van Deventer S, Zerhouni E, Zohar D.

Nat Biotechnol. 2016 Jun 9;34(6):666. doi: 10.1038/nbt0616-666d. No abstract available.

PMID:
27281427
18.

Community crystal gazing.

Acharya A, Bingham K, Bradner J, Burke W, Charo RA, Cherry J, Choulika A, Coles T, Cook-Deegan R, Crooke ST, Díaz E, Erickson B, Giddings LV, Giwa SE, Greenwood JC, Gulati V, Hall S, Harris J, Heywood J, Hill C, Levin J, Mangubat A, Maraganore J, Mariggi G, Mazur BJ, McGuire AL, Moll N, Moreno J, Naughton G, Nelsen L, Osbourn J, Perez D, Reed J, Schmidt E, Seyfert-Margolis V, Stoffels P, Thorball J, O'Toole T, Vainu I, van Deventer S, Zerhouni E, Zohar D.

Nat Biotechnol. 2016 Mar;34(3):276-83. doi: 10.1038/nbt.3515. No abstract available. Erratum in: Nat Biotechnol. 2016 Jun;34(6):666. Crook, Stanley T [Corrected to Crooke, Stanley T]. Nat Biotechnol. 2016 Jun 9;34(6):666.

PMID:
26963550
19.

Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.

Costanzo MR, Stevenson LW, Adamson PB, Desai AS, Heywood JT, Bourge RC, Bauman J, Abraham WT.

JACC Heart Fail. 2016 May;4(5):333-44. doi: 10.1016/j.jchf.2015.11.011. Epub 2016 Feb 10.

20.

How common are ALS plateaus and reversals?

Bedlack RS, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R, Macklin EA, Schoenfeld D, Cudkowicz M, Sherman A.

Neurology. 2016 Mar 1;86(9):808-12. doi: 10.1212/WNL.0000000000002251. Epub 2015 Dec 9.

21.

Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure.

Costanzo MR, Negoianu D, Jaski BE, Bart BA, Heywood JT, Anand IS, Smelser JM, Kaneshige AM, Chomsky DB, Adler ED, Haas GJ, Watts JA, Nabut JL, Schollmeyer MP, Fonarow GC.

JACC Heart Fail. 2016 Feb;4(2):95-105. doi: 10.1016/j.jchf.2015.08.005. Epub 2015 Oct 28.

22.

New approach for analyzing self-reporting of insomnia symptoms reveals a high rate of comorbid insomnia across a wide spectrum of chronic diseases.

Katic B, Heywood J, Turek F, Chiauzzi E, Vaughan TE, Simacek K, Wicks P, Jain S, Winrow C, Renger JJ.

Sleep Med. 2015 Nov;16(11):1332-1341. doi: 10.1016/j.sleep.2015.07.024. Epub 2015 Aug 21.

23.

Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial.

Costanzo MR, Negoianu D, Fonarow GC, Jaski BE, Bart BA, Heywood JT, Nabut JL, Schollmeyer MP.

Am Heart J. 2015 Sep;170(3):471-82. doi: 10.1016/j.ahj.2015.05.019. Epub 2015 Jun 14.

PMID:
26385030
24.

Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1.

Lee R, Reese C, Perry B, Heywood J, Bonner M, Zemskova M, Silver RM, Hoffman S, Tourkina E.

Fibrogenesis Tissue Repair. 2015 Jun 20;8:11. doi: 10.1186/s13069-015-0028-7. eCollection 2015.

25.

Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.

Fajardo J, Heywood JT, Patterson JH, Adams K, Chow SL.

Expert Rev Cardiovasc Ther. 2015;13(7):743-51. doi: 10.1586/14779072.2015.1051034. Epub 2015 May 31. Review.

PMID:
26028173
26.

Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D).

Heywood J, Evangelou M, Goymer D, Kennet J, Anselmiova K, Guy C, O'Brien C, Nutland S, Brown J, Walker NM, Todd JA, Waldron-Lynch F.

Trials. 2015 Mar 11;16:86. doi: 10.1186/s13063-015-0583-7.

27.

Linking regional variation of epibiotic bacterial diversity and trophic ecology in a new species of Kiwaidae (Decapoda, Anomura) from East Scotia Ridge (Antarctica) hydrothermal vents.

Zwirglmaier K, Reid WD, Heywood J, Sweeting CJ, Wigham BD, Polunin NV, Hawkes JA, Connelly DP, Pearce D, Linse K.

Microbiologyopen. 2015 Feb;4(1):136-50. doi: 10.1002/mbo3.227. Epub 2014 Dec 16.

28.

Data donation could power the learning health care system, including special access programs.

Wicks P, Heywood JA.

Am J Bioeth. 2014;14(11):27-9. doi: 10.1080/15265161.2014.957627. No abstract available.

PMID:
25325808
29.

Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry.

Ziaeian B, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC.

J Am Coll Cardiol. 2014 Aug 26;64(8):797-807. doi: 10.1016/j.jacc.2014.05.060.

30.

Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry.

Reese C, Lee R, Bonner M, Perry B, Heywood J, Silver RM, Tourkina E, Visconti RP, Hoffman S.

Front Pharmacol. 2014 Jun 16;5:141. doi: 10.3389/fphar.2014.00141. eCollection 2014.

31.

Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis.

Lee R, Perry B, Heywood J, Reese C, Bonner M, Hatfield CM, Silver RM, Visconti RP, Hoffman S, Tourkina E.

Front Pharmacol. 2014 Jun 11;5:140. doi: 10.3389/fphar.2014.00140. eCollection 2014.

32.

Economic and environmental benefits of higher-octane gasoline.

Speth RL, Chow EW, Malina R, Barrett SR, Heywood JB, Green WH.

Environ Sci Technol. 2014 Jun 17;48(12):6561-8. doi: 10.1021/es405557p. Epub 2014 May 28.

PMID:
24870412
33.

The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.

Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL.

Circ Arrhythm Electrophysiol. 2014 Jun;7(3):370-6. doi: 10.1161/CIRCEP.113.001212. Epub 2014 May 17.

PMID:
24838004
34.

Straight talk with...Jamie Heywood.

Heywood J, Zeliadt N.

Nat Med. 2014 May;20(5):457. doi: 10.1038/nm0514-457.

PMID:
24804743
35.

Did liberalising bar hours decrease traffic accidents?

Green CP, Heywood JS, Navarro M.

J Health Econ. 2014 May;35:189-98. doi: 10.1016/j.jhealeco.2014.03.007. Epub 2014 Mar 25.

PMID:
24721184
36.

Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.

Reese C, Perry B, Heywood J, Bonner M, Visconti RP, Lee R, Hatfield CM, Silver RM, Hoffman S, Tourkina E.

Arthritis Rheumatol. 2014 Jul;66(7):1909-19. doi: 10.1002/art.38572.

37.

Subjects no more: what happens when trial participants realize they hold the power?

Wicks P, Vaughan T, Heywood J.

BMJ. 2014 Jan 28;348:g368. doi: 10.1136/bmj.g368. Review. No abstract available. Erratum in: BMJ. 2014;348:g3383.

38.

The contribution of glycemic control to impaired growth during puberty in young people with type 1 diabetes and microalbuminuria.

Marcovecchio ML, Heywood JJ, Dalton RN, Dunger DB.

Pediatr Diabetes. 2014 Jun;15(4):303-8. doi: 10.1111/pedi.12090. Epub 2013 Dec 9.

PMID:
24320564
39.

Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.

Wilcox JE, Fonarow GC, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW.

Circ Heart Fail. 2014 Jan;7(1):146-53. doi: 10.1161/CIRCHEARTFAILURE.113.000789. Epub 2013 Oct 31.

PMID:
24178311
40.

Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.

Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL 2nd, Patterson JH, Vardeny O, Massie BM.

J Card Fail. 2013 May;19(5):354-69. doi: 10.1016/j.cardfail.2013.02.002. Epub 2013 Apr 6.

PMID:
23663818
41.

Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.

Milfred-LaForest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL 2nd, Patterson JH, Vardeny O, Massie BM.

Pharmacotherapy. 2013 May;33(5):529-48. doi: 10.1002/phar.1295.

PMID:
23649813
42.

ALS Untangled No. 20: the Deanna protocol.

ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):319-23. doi: 10.3109/21678421.2013.788405. Epub 2013 May 2. Review. No abstract available.

PMID:
23638638
43.

An implantable left atrial pressure sensor lead designed for percutaneous extraction using standard techniques.

Pretorius V, Birgersdotter-Green U, Heywood JT, Hafelfinger W, Gutfinger DE, Eigler NL, Love CJ, Abraham WT.

Pacing Clin Electrophysiol. 2013 May;36(5):570-7. doi: 10.1111/pace.12111. Epub 2013 Feb 28.

44.

Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF.

Shukla A, Curtis AB, Mehra MR, Albert NM, Gheorghiade M, Heywood JT, Liu Y, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC.

Pacing Clin Electrophysiol. 2013 Apr;36(4):433-43. doi: 10.1111/pace.12090. Epub 2013 Feb 4.

PMID:
23380000
45.

Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.

Besser RE, Shields BM, Hammersley SE, Colclough K, McDonald TJ, Gray Z, Heywood JJ, Barrett TG, Hattersley AT.

Pediatr Diabetes. 2013 May;14(3):181-8. doi: 10.1111/pedi.12008. Epub 2013 Jan 4.

PMID:
23289766
46.

Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF.

Reynolds D, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mcbride ML, Inge PJ, Mehra MR, O'Connor CM, Walsh MN, Yancy CW, Fonarow GC.

J Natl Med Assoc. 2012 May-Jun;104(5-6):287-98.

PMID:
22973678
47.

Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.

Talatinian A, Chow SL, Heywood JT.

Pharmacotherapy. 2012 Sep;32(9):827-37. doi: 10.1002/j.1875-9114.2012.01104.x. Review.

PMID:
22949142
48.

The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy.

Kato M, Stevenson LW, Palardy M, Campbell PM, May CW, Lakdawala NK, Stewart G, Nohria A, Rogers JG, Heywood JT, Gheorghiade M, Lewis EF, Mi X, Setoguchi S.

J Card Fail. 2012 Jul;18(7):524-33. doi: 10.1016/j.cardfail.2012.04.012. Epub 2012 May 30.

49.

Threshold crossing of device-based intrathoracic impedance trends identifies relatively increased mortality risk.

Tang WH, Warman EN, Johnson JW, Small RS, Heywood JT.

Eur Heart J. 2012 Sep;33(17):2189-96. doi: 10.1093/eurheartj/ehs121. Epub 2012 Jun 7.

50.

A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease.

Costanzo MR, Heywood JT, Massie BM, Iwashita J, Henderson L, Mamatsashvili M, Sisakian H, Hayrapetyan H, Sager P, van Veldhuisen DJ, Albrecht D.

Eur J Heart Fail. 2012 Aug;14(8):922-30. doi: 10.1093/eurjhf/hfs074. Epub 2012 May 21.

Supplemental Content

Loading ...
Support Center